<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Healthanomics &#187; 2001</title>
	<atom:link href="http://www.healthanomics.ca/category/year/2001/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.healthanomics.ca</link>
	<description>A collection of work and information about decision making in health</description>
	<lastBuildDate>Thu, 12 Aug 2010 05:28:04 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>A rapid and systematic review of the clinical effectiveness and cost effectiveness of gemcitabine for the treatment of pancreatic cancer</title>
		<link>http://www.healthanomics.ca/2001/12/a-rapid-and-systematic-review-of-the-clinical-effectiveness-and-cost-effectiveness-of-gemcitabine-for-the-treatment-of-pancreatic-cancer/</link>
		<comments>http://www.healthanomics.ca/2001/12/a-rapid-and-systematic-review-of-the-clinical-effectiveness-and-cost-effectiveness-of-gemcitabine-for-the-treatment-of-pancreatic-cancer/#comments</comments>
		<pubDate>Sun, 02 Dec 2001 00:02:36 +0000</pubDate>
		<dc:creator>Nick</dc:creator>
				<category><![CDATA[2001]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Economic evaluation]]></category>
		<category><![CDATA[Meta analysis]]></category>
		<category><![CDATA[Papers]]></category>
		<category><![CDATA[Paper]]></category>

		<guid isPermaLink="false">http://www.healthanomics.ca/?p=113</guid>
		<description><![CDATA[Ward S, Morris E, Bansback N, Calvert N, Crellin A, Forman D, Larvin M, Radstone D
Health Technol Assess. 2001;5(24):1-70
]]></description>
			<content:encoded><![CDATA[<p></p><p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Ward%20S%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Ward S</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Morris%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Morris E</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Bansback%20N%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Bansback N</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Calvert%20N%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Calvert N</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Crellin%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Crellin A</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Forman%20D%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Forman D</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Larvin%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Larvin M</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Radstone%20D%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Radstone D</a></p>
<p><a title="Health technology assessment (Winchester, England)." href="javascript:AL_get(this,%20'jour',%20'Health%20Technol%20Assess.');">Health Technol Assess.</a> 2001;5(24):1-70</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthanomics.ca/2001/12/a-rapid-and-systematic-review-of-the-clinical-effectiveness-and-cost-effectiveness-of-gemcitabine-for-the-treatment-of-pancreatic-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer</title>
		<link>http://www.healthanomics.ca/2001/12/a-rapid-and-systematic-review-of-the-evidence-for-the-clinical-effectiveness-and-cost-effectiveness-of-irinotecan-oxaliplatin-and-raltitrexed-for-the-treatment-of-advanced-colorectal-cancer/</link>
		<comments>http://www.healthanomics.ca/2001/12/a-rapid-and-systematic-review-of-the-evidence-for-the-clinical-effectiveness-and-cost-effectiveness-of-irinotecan-oxaliplatin-and-raltitrexed-for-the-treatment-of-advanced-colorectal-cancer/#comments</comments>
		<pubDate>Sat, 01 Dec 2001 23:39:57 +0000</pubDate>
		<dc:creator>Nick</dc:creator>
				<category><![CDATA[2001]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Economic evaluation]]></category>
		<category><![CDATA[Meta analysis]]></category>
		<category><![CDATA[Papers]]></category>
		<category><![CDATA[Paper]]></category>

		<guid isPermaLink="false">http://www.healthanomics.ca/?p=89</guid>
		<description><![CDATA[Lloyd Jones M, Hummel S, Bansback N, Orr B, Seymour M
Health Technol Assess. 2001;5(25):1-128
]]></description>
			<content:encoded><![CDATA[<p></p><p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Lloyd%20Jones%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Lloyd Jones M</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Hummel%20S%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Hummel S</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Bansback%20N%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Bansback N</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Orr%20B%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Orr B</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Seymour%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract">Seymour M</a></p>
<p><a title="Health technology assessment (Winchester, England)." href="javascript:AL_get(this,%20'jour',%20'Health%20Technol%20Assess.');">Health Technol Assess.</a> 2001;5(25):1-128</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthanomics.ca/2001/12/a-rapid-and-systematic-review-of-the-evidence-for-the-clinical-effectiveness-and-cost-effectiveness-of-irinotecan-oxaliplatin-and-raltitrexed-for-the-treatment-of-advanced-colorectal-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
